Grants

Prognostic and predictive factors in patients with metastatic renal cell carcinoma treated with tyrosine kinase inhibitors (NV15-34678A), Czech Health Research Council (2015 – 2018)

Study of urinary/tissue microRNAs as potential biomarkers of urothelial carcinoma of the urinary bladder (NV15-31071A), Czech Health Research Council (2015 – 2018)

New level of glioblastoma molecular taxonomy based on the expression profiling of long non-coding RNAs: implications for diagnosis and therapy (NV15-33158A), Czech Health Research Council (2015 – 2018)

Usage of cerebrospinal fluid microRNAs in diagnosis of brain tumors (NV15-34553A), Czech Health Research Council (2015 – 2018)

Molecularly guided radiotherapy or radiochemotherapy based on microRNA profile in head and neck cancer patients- a feasibility study (NV15-31627A), Czech Health Research Council (2015 – 2018)

Usage of circulating microRNAs for the diagnosis of pancreatic cancer and identification of patients who will not benefit from the surgical resection (NV16-31314A), Czech Health Research Council (2016 – 2019)

Utility of tissue/circulating microRNAs for response prediction and improvement of restaging accuracy in rectal cancer after neoadjuvant treatment (NV16-31765A), Czech Health Research Council (2016 – 2019)

Diagnostic and prognostic impact of miRNA expression profiles related to morphological heterogeneity in triple‐negative breast cancer (NV16-31997A), Czech Health Research Council (2016 – 2019)

Genome-wide expression profiling and mutation analysis as the diagnostic basis for personalized pediatric cancer treatment plans: a feasibility study (NV16-33209A), Czech Health Research Council (2016 – 2019)

Uncovering the mechanism underlying the tumor-suppressive effects of miR-215 and its substitution as new therapeutic strategy in colorectal cancer (GA16-18257S), The Czech Science Foundation (2016 – 2018)